Vimarsana
Biggest News Aggregation in the World

Page 2 - Johan Dalsgaard News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johan Dalsgaard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johan Dalsgaard Today - Breaking & Trending Today

Vicore has carried out a directed share issue of 10,000,000 shares at a subscription price of SEK 20 per share, raising gross proceeds of SEK 200 million - Vimarsana News

Vicore has carried out a directed share issue of 10,000,000 shares at a subscription price of SEK 20 per share, raising gross proceeds of SEK 200 million

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore" or the "Company"), a pioneer in the development of angiotensin II type 2 receptor agonists (ATRAGs),...

Vicore intends to carry out a directed share issue - Vimarsana News

Vicore intends to carry out a directed share issue

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore" or the "Company"), a pioneer in the development of angiotensin II type 2 receptor agonists (ATRAGs),...

Vicore Pharma Holding AB: Vicore intends to carry out a directed share issue - Vimarsana News

Vicore Pharma Holding AB: Vicore intends to carry out a directed share issue

STOCKHOLM, Dec. 7, 2022 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore" or the "Company"), a pioneer in the development of angiotensin II type 2 receptor agonists (ATRAGs), announces

Vicore intends to carry out a directed share issue - Vimarsana News

Vicore intends to carry out a directed share issue

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore" or the "Company"), a pioneer in the development of angiotensin II type 2 receptor agonists (ATRAGs),...

Vicore announces first patient enrolled in COMPANION; a digital therapeutic pivotal study for patients with pulmonary fibrosis - Vimarsana News

Vicore announces first patient enrolled in COMPANION; a digital therapeutic pivotal study for patients with pulmonary fibrosis

/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a pioneer in the development of angiotensin II type 2 receptor agonists (ATRAGs), today launched...